Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.17% | -16.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.17% | -16.94% | |||
| Cost of Revenue | 1.29% | 4.49% | |||
| Gross Profit | 0.56% | -59.26% | |||
| SG&A Expenses | -2.50% | -4.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.59% | 0.40% | |||
| Operating Income | 2.83% | -36.83% | |||
| Income Before Tax | -40.68% | -13.31% | |||
| Income Tax Expenses | -2,746.91% | 2,414.29% | |||
| Earnings from Continuing Operations | -32.13% | -13.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 32.03% | 12.57% | |||
| Net Income | -32.21% | -14.53% | |||
| EBIT | 2.83% | -36.83% | |||
| EBITDA | 6.13% | -65.84% | |||
| EPS Basic | -31.47% | -13.23% | |||
| Normalized Basic EPS | 233.76% | -782.61% | |||
| EPS Diluted | -31.47% | -13.23% | |||
| Normalized Diluted EPS | 233.76% | -782.61% | |||
| Average Basic Shares Outstanding | 0.57% | 1.14% | |||
| Average Diluted Shares Outstanding | 0.57% | 1.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||